Shinpoong Pharmaceutical Co., Ltd. (019170) Stock Statistics & Valuation Metrics

Shinpoong Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 429.76B. The enterprise value is KRW 433.99B.

Market Cap

KRW 429.76B

Enterprise Value

KRW 433.99B

Shinpoong Pharmaceutical Co., Ltd. has 52,418,520 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

52,418,520

Owned by Insiders

―

Owned by Institutions

4.19%

Shinpoong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 4.29%.

Return on Equity (ROE)

0.03

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

4.29%

Return on Capital Employed (ROCE)

0.05

Revenue Per Employee

287.95M

Profits Per Employee

10.83M

Employee Count

815

Asset Turnover

0.67

Inventory Turnover

2.26

The current PE Ratio of Shinpoong Pharmaceutical Co., Ltd. is -821.99. Shinpoong Pharmaceutical Co., Ltd.’s PEG ratio is 6.07.

PE Ratio

-821.99

PS Ratio

1.70

PB Ratio

1.52

Price to FCF

29.90

Price to Operating Cash Flow

23.99

PEG Ratio

6.07

In the last 12 months, Shinpoong Pharmaceutical Co., Ltd. had revenue of 234.68B and earned 8.83B in profits. Earnings per share was 172.00.

Revenue

234.68B

Gross Profit

102.37B

Operating Income

14.26B

Pretax Income

8.45B

Net Income

8.83B

EBITDA

25.65B

Earnings Per Share (EPS)

172.00

In the last 12 months, operating cash flow was 17.57B and capital expenditures -3.99B, giving a free cash flow of 13.57B billion.

Operating Cash Flow

17.57B

Free Cash Flow

13.57B

Free Cash Flow per Share

252.77

Shinpoong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

3.19%

Earnings Yield

-0.18%

Beta

0.30

52-Week Price Change

-41.95%

50-Day Moving Average

9395.20

200-Day Moving Average

10010.35

Relative Strength Index (RSI)

38.40

Average Volume (3m)

519.75K

Shinpoong Pharmaceutical Co., Ltd. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 14, 2026

Next Earnings Date

Nov 18, 2026

Ex-Dividend Date

―

Shinpoong Pharmaceutical Co., Ltd. as a current ratio of 3.09, with Debt / Equity ratio of 20.69%

Current Ratio

3.09

Quick Ratio

2.22

Debt to Market Cap

0.07

Net Debt to EBITDA

0.33

Interest Coverage Ratio

5.30

In the past 12 months, Shinpoong Pharmaceutical Co., Ltd. has paid 62.48M in taxes.

Income Tax

62.48M

Effective Tax Rate

0.01

Shinpoong Pharmaceutical Co., Ltd. EV to EBITDA ratio is 29.53, with an EV/FCF ratio of 31.70.

EV to Sales

1.80

EV to EBITDA

29.53

EV to Free Cash Flow

31.70

EV to Operating Cash Flow

24.49

Shinpoong Pharmaceutical Co., Ltd. has KRW 72.30B in cash and marketable securities with KRW 53.28B in debt, giving a net cash position of KRW 19.02B billion.

Cash & Marketable Securities

KRW 72.30B

Total Debt

KRW 53.28B

Net Cash

KRW 19.02B

Net Cash Per Share

KRW 362.77

Tangible Book Value Per Share

KRW 5,080.00

Gross margin is 42.36%, with operating margin of 1.07%, and net profit margin of -0.34%.

Gross Margin

42.36%

Operating Margin

1.07%

Pretax Margin

<0.01%

Net Profit Margin

-0.34%

EBITDA Margin

6.09%

EBIT Margin

1.36%

The average price target for Shinpoong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

6.21%

EPS Growth Forecast

95.65%

Smart Score

―

AI Score

51